Jay Kenik, MD
Rheumatology · Omaha, NENPI 1063522266
Payments from drug & device makers
Across 757 payments — averaging $90.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$31K
- Amgen$29K
- Lilly USA, LLC$1K
- Aurinia Pharma U.S., Inc.$977
- ANI Pharmaceuticals, Inc.$845
- Johnson & Johnson$653
- plus $5K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 129 | $31,204 |
| Amgen(2 entities) | 182 | $29,149 |
| Lilly USA, LLC | 61 | $1,093 |
| Aurinia Pharma U.S., Inc. | 57 | $977 |
| ANI Pharmaceuticals, Inc. | 30 | $845 |
| Johnson & Johnson | 38 | $653 |
| UCB, Inc. | 55 | $648 |
| AstraZeneca(2 entities) | 23 | $587 |
| GSK | 18 | $368 |
| Novartis | 19 | $361 |
| Sun Pharmaceutical Industries Inc. | 20 | $354 |
| Pfizer | 22 | $350 |
| Genentech USA, Inc. | 9 | $203 |
| Cardinal Health 110 LLC | 2 | $200 |
| Incyte Corporation | 11 | $198 |
| Sandoz | 12 | $194 |
| Bristol Myers Squibb | 16 | $156 |
| Regeneron Healthcare Solutions, Inc. | 5 | $153 |
| Sanofi | 7 | $131 |
| Boehringer Ingelheim | 5 | $95 |
| Mallinckrodt Hospital Products Inc. | 4 | $90 |
| Sobi, Inc | 5 | $86 |
| Kyowa Kirin, Inc. | 4 | $63 |
| Fresenius Kabi USA, LLC | 4 | $63 |
| LEO Pharma Inc. | 3 | $44 |
| Ultragenyx Pharmaceutical Inc. | 2 | $43 |
| Organon | 2 | $35 |
| Mallinckrodt Enterprises LLC | 1 | $30 |
| Novo Nordisk | 2 | $29 |
| Pharming Healthcare, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Radius Health, Inc. | 1 | $18 |
| Almirall LLC | 1 | $17 |
| Dermavant Sciences, Inc. | 1 | $16 |
| Bayer | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Fresenius USA Marketing, Inc. | 1 | $14 |
| Arcutis Biotherapeutics, Inc. | 1 | $13 |
How this compares
$68,550 in reported general payments places this provider in the 85th percentile of 39 rheumatology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Omaha
- William PalmerOmaha$534K
- Ted MikulsOmaha$433K
- Abhijeet DanveOmaha$118K
- Michael FeelyOmaha$93K
- Lynell KlassenOmaha$68K
- Amandeep RakhraOmaha$12K
- Carolyn CoyleOmaha$6K
- Joseph NahasOmaha$6K
- James OdellOmaha$4K
- Kathryn WildyOmaha$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.